These patients must adhere to medication more than 1 year and they are defined as antiviral drug resistance when presenting one of the situations such as primary non-response (decreasing of serum HBV DNA < 2 log10 IU / mL after at least 24 weeks of treatment) or virologic breakthrough or biochemical breakthrough.